155 related articles for article (PubMed ID: 33069729)
1. Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma.
Jacków J; Rami A; Hayashi R; Hansen C; Guo Z; DeLorenzo D; Pappalardo A; Alvarez Cespedes D; Kim AL; Perez-Lorenzo R; Owens DM; Christiano AM
J Invest Dermatol; 2021 Apr; 141(4):942-946. PubMed ID: 33069729
[No Abstract] [Full Text] [Related]
2. Pembrolizumab for Treatment of a Patient With Multiple Cutaneous Squamous Cell Carcinomas and Recessive Dystrophic Epidermolysis Bullosa.
Piccerillo A; El Hachem M; De Vito R; De Luca EV; Peris K
JAMA Dermatol; 2020 Jun; 156(6):708-710. PubMed ID: 32320041
[No Abstract] [Full Text] [Related]
3. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
South AP; O'Toole EA
Dermatol Clin; 2010 Jan; 28(1):171-8. PubMed ID: 19945632
[TBL] [Abstract][Full Text] [Related]
4. Genetic Profiles of Squamous Cell Carcinomas Associated with Recessive Dystrophic Epidermolysis Bullosa Unveil NOTCH and TP53 Mutations and an Increased MYC Expression.
Sans-DeSanNicolas L; Caratú G; Vidal-Cortés O; Sanchez-Redondo S; Ferrer B; Mancuso F; González-Sanchez E; Pérez-Alea M; McGrail K; Hernandez-Losa J; Bodet D; Vivancos A; Garcia-Patos V; Recio JA
J Invest Dermatol; 2018 Jun; 138(6):1423-1427. PubMed ID: 29291383
[No Abstract] [Full Text] [Related]
5. Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC.
Martins VL; Caley MP; Moore K; Szentpetery Z; Marsh ST; Murrell DF; Kim MH; Avari M; McGrath JA; Cerio R; Kivisaari A; Kähäri VM; Hodivala-Dilke K; Brennan CH; Chen M; Marshall JF; O'Toole EA
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26476432
[TBL] [Abstract][Full Text] [Related]
6. Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: an enigmatic entity with complex pathogenesis.
Rodeck U; Uitto J
J Invest Dermatol; 2007 Oct; 127(10):2295-6. PubMed ID: 17853916
[TBL] [Abstract][Full Text] [Related]
7. A recurrent nonsense mutation occurring as a de novo event in a patient with recessive dystrophic epidermolysis bullosa.
Cuadrado-Corrales N; Sánchez-Jimeno C; García M; Ayuso C; De Lucas R; Vicario JL; Conti CJ; Zambruno G; Escamez MJ; Del Rio M
Dermatology; 2011; 223(3):219-21. PubMed ID: 21849769
[No Abstract] [Full Text] [Related]
8. Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa.
Tartaglia G; Cao Q; Padron ZM; South AP
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065916
[TBL] [Abstract][Full Text] [Related]
9. Cemiplimab treatment of squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
Vasilev P; Kalev D; Karamanliev M; Dimitrov D; Troyanova P; Yordanova I
J Dtsch Dermatol Ges; 2023 Mar; 21(3):295-297. PubMed ID: 36855845
[No Abstract] [Full Text] [Related]
10. Cancer. An anchor for tumor cell invasion.
Yuspa SH; Epstein EH
Science; 2005 Mar; 307(5716):1727-8. PubMed ID: 15774745
[No Abstract] [Full Text] [Related]
11. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa.
Kim M; Murrell DF
Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672
[TBL] [Abstract][Full Text] [Related]
12. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.
Pourreyron C; Cox G; Mao X; Volz A; Baksh N; Wong T; Fassihi H; Arita K; O'Toole EA; Ocampo-Candiani J; Chen M; Hart IR; Bruckner-Tuderman L; Salas-Alanis JC; McGrath JA; Leigh IM; South AP
J Invest Dermatol; 2007 Oct; 127(10):2438-44. PubMed ID: 17495952
[TBL] [Abstract][Full Text] [Related]
13. Inherited epidermolysis bullosa dystrophica and squamous cell carcinoma- A case report.
Gayathri E; Anbukkarasi K; Lilly SM
Indian J Pathol Microbiol; 2023; 66(2):360-362. PubMed ID: 37077084
[TBL] [Abstract][Full Text] [Related]
14. Significance of sentinel node biopsy in the management of squamous cell carcinoma arising from recessive dystrophic epidermolysis bullosa.
Rokunohe A; Nakano H; Aizu T; Kaneko T; Nakajima K; Ikenaga S; Matsuzaki Y; Murai T; Tamai K; Sawamura D
J Dermatol; 2008 Jun; 35(6):336-40. PubMed ID: 18578710
[TBL] [Abstract][Full Text] [Related]
15. Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita.
Watanabe M; Natsuga K; Shinkuma S; Shimizu H
J Dermatol; 2018 May; 45(5):515-521. PubMed ID: 29352483
[TBL] [Abstract][Full Text] [Related]
16. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth.
Sen M; Pollock NI; Black J; DeGrave KA; Wheeler S; Freilino ML; Joyce S; Lui VW; Zeng Y; Chiosea SI; Grandis JR
Neoplasia; 2015 Mar; 17(3):256-64. PubMed ID: 25810010
[TBL] [Abstract][Full Text] [Related]
17. Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma.
Kim M; Li M; Intong LR; Tran K; Melbourne W; Marucci D; Bucci J; de Souza P; Mallesara G; Murrell DF
Br J Dermatol; 2013 Jul; 169(1):208-10. PubMed ID: 23398414
[No Abstract] [Full Text] [Related]
18. Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
Reimer A; Lu S; He Y; Bruckner-Tuderman L; Technau-Hafsi K; Meiss F; Has C; von Bubnoff D
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):e1-e3. PubMed ID: 31374134
[No Abstract] [Full Text] [Related]
19. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica.
Yamada M; Hatta N; Sogo K; Komura K; Hamaguchi Y; Takehara K
Dermatol Surg; 2004 Nov; 30(11):1424-9. PubMed ID: 15522026
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa. A report of 4 patients with 17 primary cutaneous malignancies.
Newman C; Wagner RF; Tyring SK; Spigel GT
J Dermatol Surg Oncol; 1992 Apr; 18(4):301-5. PubMed ID: 1560154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
